About this Research Topic
There has been a recent resurgence of interest in hypertriglyceridemia, in part because it remains a residual risk factor for cardiovascular disease even after the lowering of low-density lipoproteins with statins. New information resulting from genetic studies has provided important insights into the pathogenesis of hypertriglyceridemia and has generated substantial interest in new drug targets aimed at lowering triglyceride levels while reducing the consequences of hypertriglyceridemia. This Research Topic aims to provide a comprehensive view of topical areas related to hypertriglyceridemia in the form of Review articles.
The following themes will be covered in this collection:
1. Features and Mechanisms of Hypertriglyceridemia
2. Genetics of Hypertiglyceridemia
3. Insulin Resistance and Dyslipidemia
4. Role of the Gut in Diabetic Dyslipidemia
5. Dietary Impact on Postprandial Lipemia
6. Hypertriglyceridemia and Cardiovascular Disease: Association or Cause?
7. Apo CIII, Hypertriglyceridemia and Cardiovascular Disease
8. Hypertriglyceridemia: What Have We Learned from Animal Models?
9. The Chylomicornemia Syndrome
10. Current and Future Therapies to Prevent Cardiovascular Disease in Patients with Hypertriglyceridemia
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.